On 13 April 2025, our third site investigator meeting convened 16 representatives from 11 sites across five countries, along with […]
Category: Newsroom
Launch of the id.DRIVE respiratory syncytial virus (RSV) vaccine effectiveness study with the first site activation on 29 August 2024.
Universitätsklinikum Frankfurt in Germany was the first study site to be activated for the RSV vaccine effectiveness study in adults […]
Second in-person Site Investigator meeting
On 28 April 2024, the second in-person Study Contributor (Site) Investigator meeting took place as a satellite meeting during the […]
Poster presentation during ESCMID Global 2024
During the 34th Congress of the European Society of Clinical Microbiology and Infectious Diseases (ESCMID) held in Barcelona, Spain on […]
id.DRIVE welcomes 3 new members to its Independent Scientific Committee
With id.DRIVE´s expansion of scope beyond COVID-19 and broadened studies’ portfolio, we recently extended the breadth of expertise and number […]
id.DRIVE has activated a new Study Contributor (study site) in Italy
id.DRIVE has activated Luigi Sacco Hospital on February 28th, 2024. Luigi Sacco Hospital is located in north Milan, Italy, and […]
COVIDRIVE expands its scope of studies and becomes id.DRIVE: new European partnership for burden and effectiveness studies on infectious diseases.
id.DRIVE is a Public-Private-Partnership, which consists of a unique consortium of pharmaceutical companies, public health institutes and research groups who […]
Site Investigators’ meeting
COVIDRIVE´s second virtual site investigators meeting took place on December 14th, 2023. We welcomed participants from sites in Spain, Italy, […]
Second annual face-to-face COVIDRIVE Steering Committee meeting
On November 28th and 29th, 2023, the members of the COVIDRIVE Steering Committee met in Valencia, Spain to discuss the […]
COVIDRIVE has reached a milestone: enrolment of over 10,000 patients
We are pleased to announce that the first COVIDRIVE study has recruited 10,038 patients across 17 hospitals in 5 European countries. This high recruitment number is important […]